Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986408 in Advanced Solid Tumors
NCT05407675Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of BMS-986408 in solid tumor (advanced stage), sponsored by Bristol Myers Squibb. Started Aug 2022; status: completed.
02
Drugs
BMS-986408
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05407675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05407675.